Category Archives: Regional News

You are here: Home » Category: "Regional News"

Onconova Therapeutics to Present at the BIO International Convention

NEWTOWN, Pa., June 13, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), today announced that Dr. Ramesh Kumar, President & CEO, will present a corporate overview at the…

[Read More]

Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference

DUBLIN, Ireland and TREVOSE, Pa., June 13, 2017 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will participate in the JMP Securities Life Science Conference. Matthew Pauls, president and chief executive officer of…

[Read More]

BioCryst to Present at the JMP Securities 2017 Life Sciences Conference

RESEARCH TRIANGLE PARK, N.C., June 13, 2017 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that executives from the Company are scheduled to provide a corporate summary and update regarding the Company’s clinical programs at the JMP Securities 2017 Life Sciences Conference in New York on Wednesday, June 21, 2017 at 9:30 a.m. Eastern…

[Read More]

PSI Named Among Computerworld Best Places to Work in IT for 2nd Consecutive Year

ARLINGTON, Va., June 12, 2017 (GLOBE NEWSWIRE) — Planned Systems International, Inc. (PSI), a leading provider of information technology (IT) solutions and services for the federal government, is pleased to announce that it has been recognized among the 100 Best Places to Work for technology professionals by IDG’s Computerworld. This is the second year in…

[Read More]

Shopko Named as Kick-Off Partner for Lemonade for Livy to Support Local Epilepsy Foundations

GREEN BAY, Wis., June 12, 2017 (GLOBE NEWSWIRE) — Epilepsy Foundation’s Lemonade for Livy initiative has named national retail chain, Shopko, its official kick-off partner. Originally established in Clearwater, Florida, to support Olivia “Livy” Scheinman, Lemonade for Livy raises awareness and money for epilepsy via lemonade stands all over the country. Livy was diagnosed with…

[Read More]

Fibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized Scleroderma

EXTON, Pa., June 12, 2017 (GLOBE NEWSWIRE) — Fibrocell Science, Inc., (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to FCX-013, Fibrocell’s gene therapy candidate for the treatment of moderate…

[Read More]

IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease

BETHESDA, Md., June 12, 2017 (GLOBE NEWSWIRE) — India Globalization Capital, Inc. (NYSE MKT:IGC) is pleased to announce that it has entered into a definitive license agreement with the University of South Florida making IGC the exclusive licensee of the U.S. patent filing entitled “THC as a Potential Therapeutic Agent for Alzheimer’s Disease.” By acquiring…

[Read More]

BioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG

MALVERN, Pa. and ZUG, Switzerland, June 09, 2017 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders…

[Read More]

TissuGlu® Surgical Adhesive enables drain-free recovery in patients undergoing DIEP flap breast reconstruction

RALEIGH, N.C., June 08, 2017 (GLOBE NEWSWIRE) — Outcomes of the SANA Gerresheim series demonstrated that effective donor-site flap closure with TissuGlu Surgical Adhesive is a viable alternative to post-surgical drains.  Dr. Sonia Fertsch presented the series, which included 41 DIEP flap breast reconstructions, at the EURAPS Research Council Meeting in Pisa last month. The…

[Read More]

Fibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa

EXTON, Pa., June 08, 2017 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the remaining two patients in the NC1+ cohort have been dosed in the Phase 1 portion of the Phase 1/2 clinical trial of FCX-007…

[Read More]